{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:43:26Z","timestamp":1791315806213,"version":"4.3.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2023-I2M-1-001"],"award-info":[{"award-number":["2023-I2M-1-001"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.hrthm.2024.12.006","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T19:28:53Z","timestamp":1733858933000},"page":"2917-2923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Implications of primary bradycardia in patients with hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7914-9569","authenticated-orcid":false,"given":"Jingying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianming","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2024.12.006_bib1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.12.006_bib2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s11886-012-0297-3","article-title":"A primer on arrhythmias in patients with hypertrophic cardiomyopathy","volume":"14","author":"Bockstall","year":"2012","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.hrthm.2024.12.006_bib3","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.hrthm.2023.06.015","article-title":"Ventricular arrhythmias in patients with hypertrophic cardiomyopathy: prevalence, distribution, predictors, and outcome","volume":"20","author":"Segev","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.12.006_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad045","article-title":"Should lethal arrhythmias in hypertrophic cardiomyopathy be predicted using non-electrophysiological methods?","volume":"25","author":"Saumarez","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.12.006_bib5","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1161\/CIRCULATIONAHA.123.065037","article-title":"Evolving contemporary management of atrial fibrillation in hypertrophic cardiomyopathy","volume":"148","author":"Rowin","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.12.006_bib6","first-page":"e382","volume":"140","author":"Kusumoto","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.12.006_bib7","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.jcin.2022.06.034","article-title":"Outcomes of patients with hypertrophic obstructive cardiomyopathy and pacemaker implanted after alcohol septal ablation","volume":"15","author":"Veselka","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2024.12.006_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamacardio.2016.0252","article-title":"Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US nationwide inpatient database, 2003\u20132011","volume":"1","author":"Kim","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2024.12.006_bib9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.21037\/jtd-20-2779","article-title":"Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation","volume":"13","author":"Yang","year":"2021","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.hrthm.2024.12.006_bib10","first-page":"370","article-title":"Characteristics of primary bradyarrhythmia in hypertrophic cardiomyopathy: a 10-year, single-center analysis","volume":"9","author":"Zhang","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.hrthm.2024.12.006_bib11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0300-8932(10)70210-4","article-title":"Severe cardiac conduction disturbances and pacemaker implantation in patients with hypertrophic cardiomyopathy","volume":"63","author":"Barriales-Villa","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.hrthm.2024.12.006_bib12","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.12.006_bib13","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.12.006_bib14","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.12.006_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1148\/radiol.2021210914","article-title":"Patterns of replacement fibrosis in hypertrophic cardiomyopathy","volume":"302","author":"Liu","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.hrthm.2024.12.006_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/cells12020230","article-title":"Electrical remodelling in cardiac disease","volume":"12","author":"Ravens","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.hrthm.2024.12.006_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu205","article-title":"Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells","volume":"104","author":"Han","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2024.12.006_bib18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jacep.2022.08.003","article-title":"Molecular and functional remodeling of superior and inferior SAN in a rat model of HCM","volume":"8","author":"Gams","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.12.006_bib19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.hjc.2022.05.002","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy\u2014a contemporary mini-review","volume":"67","author":"Dragasis","year":"2022","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hrthm.2024.12.006_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev-med-042220-021539","article-title":"hypertrophic cardiomyopathy: new concepts and therapies","volume":"73","author":"Maron","year":"2022","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.hrthm.2024.12.006_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14017431.2020.1727000","article-title":"Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registry","volume":"54","author":"Valzania","year":"2020","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.hrthm.2024.12.006_bib22","article-title":"Future bradyarrhythmia in patients with hypertrophic cardiomyopathy","volume":"33","author":"Nakasuka","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.hrthm.2024.12.006_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jacc.2014.03.056","article-title":"Incidence of and risk factors for sick sinus syndrome in the general population","volume":"64","author":"Jensen","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.12.006_bib24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1532-5415.2001.49153.x","article-title":"Trends and outcomes in the hospitalization of older Americans for cardiac conduction disorders or arrhythmias, 1991\u20131998","volume":"49","author":"Baine","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.hrthm.2024.12.006_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.4176","article-title":"Risk factors associated with atrioventricular block","volume":"2","author":"Kerola","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hrthm.2024.12.006_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/eurheartj\/eht176","article-title":"Prognostic significance of prolonged PR interval in the general population","volume":"35","author":"Aro","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.12.006_bib27","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jacc.2019.05.053","article-title":"Conduction abnormalities and long-term mortality following septal myectomy in patients with obstructive hypertrophic cardiomyopathy","volume":"74","author":"Cui","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.12.006_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12968-021-00718-3","article-title":"Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy","volume":"23","author":"Chung","year":"2021","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.hrthm.2024.12.006_bib29","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1093\/eurheartjsupp\/suad125","article-title":"Burden of bradycardia and barriers to accessing bradycardia therapy in underserved countries","volume":"25","author":"Egas","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.12.006_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jacep.2021.07.007","article-title":"His-Purkinje conduction system pacing in atrioventricular block: new insights into site of conduction block","volume":"8","author":"Vijayaraman","year":"2022","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124036452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124036452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:04:13Z","timestamp":1778868253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527124036452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1547527124036452"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.12.006","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications of primary bradycardia in patients with hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}